EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Characteristics of Gut Microbiota in Patients with Chronic Obstructive Pulmonary Disease Based on Metagenomics and Metabolomics

Yanan Wang, Xiaoyan Liu, Ruiyue Gao iD, Yu An iD, Chao Ren, Li An

International Journal of Molecular Sciences · 2026

DOI: 10.3390/ijms27104213 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Yanan Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory and Critical Care Medicine, Beijing Institute of Respiratory Medicine, Beijing Chao-Yang Hospital, Capital Medical Universi…. Hauptthemen laut MEDLINE: Pulmonary Disease, Chronic Obstructive, Metagenomics, Metabolomics, Gastrointestinal Microbiome. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Beijing Chao-Yang Hospital, Beijing Municipal Science and Technology Commission, Beijing Municipal Health Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The gut–lung axis is important in Chronic Obstructive Pulmonary Disease (COPD) pathogenesis; however, most studies rely on low-resolution 16S rRNA sequencing, and integrated multi-omics investigations in Chinese COPD populations are scarce. A total of 104 participants including 74 stable COPD patients and 30 healthy controls from northern China were recruited, and shotgun metagenomic sequencing and untargeted metabolomics were performed. Results showed that alpha diversity of the gut microbiota did not differ significantly between COPD patients and healthy controls, whereas beta diversity showed clear separation. Marked differences in microbial composition from phylum to species levels (e.g., Oscillospiraceae) and altered microbial functions (signal transduction, antibiotic resistance, etc.) were observed in COPD patients. Metabolomic profiling identified 497 differential fecal metabolites and 1260 differential serum metabolites in COPD patients. Importantly, serum riboflavin levels were significantly reduced and positively correlated with pulmonary function indices as well as the key differential gut microbial functional gene K11752. Serum metabolite eremopetasinorol exhibited high diagnostic accuracy for COPD (AUC = 0.947, 95% CI: 0.8–0.98), surpassing fecal metabolites and microbial features. This study provides integrated metagenomic and metabolomic characterization of gut microbiota alterations in Chinese COPD patients, offering novel insights for biomarker discovery and targeted intervention strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pulmonary Disease, Chronic ObstructiveMetagenomicsMetabolomicsGastrointestinal MicrobiomeHumansMaleFemaleAgedMiddle AgedFecesMultiomicsMetabolomeBiomarkersRNA, Ribosomal, 16SChinaCase-Control Studies

Stichwörter der Autor:innen

chronic obstructive pulmonary diseasegut microbiotametagenomic sequencingriboflavinuntargeted metabolomics

Substanzen

BiomarkersRNA, Ribosomal, 16S

Autor:innen und Institutionen

  • Department of Respiratory and Critical Care Medicine, Beijing Institute of Respiratory Medicine, Beijing Chao-Yang Hospital, Capital Medical University, Beijing 100020, China.
  • Beijing Key Laboratory of Multimodal Intelligent Diagnosis and Treatment System for Respiratory Diseases, Beijing Chao-Yang Hospital, Capital Medical University, Beijing 100020, China.
  • Medical Research Center, Beijing Institute of Respiratory Medicine, Beijing Chao-Yang Hospital, Capital Medical University, Beijing 100020, China.

ORCID-Profile: Ruiyue Gao, Yu An

Förderung

  • Beijing Chao-Yang Hospital
  • Beijing Municipal Science and Technology Commission
  • Beijing Municipal Health Commission
  • National Health Commission of the People's Republic of China
  • Cross-disciplinary Research Project of Beijing Nova Program
  • Capital’s Funds for Health Improvement and Research
  • Chinese National Science and Technology Innovation 2030, Noncommunicable Chronic Diseases-National Science and Technology Major Project

Zitieren

APA

Wang, Y., Liu, X., Gao, R., An, Y., Ren, C., & An, L. (2026). Characteristics of Gut Microbiota in Patients with Chronic Obstructive Pulmonary Disease Based on Metagenomics and Metabolomics. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27104213

Vancouver

Wang Y, Liu X, Gao R, An Y, Ren C, An L. Characteristics of Gut Microbiota in Patients with Chronic Obstructive Pulmonary Disease Based on Metagenomics and Metabolomics. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27104213

BibTeX
@article{Wang2026,
  author = {Wang, Yanan and Liu, Xiaoyan and Gao, Ruiyue and An, Yu and Ren, Chao and An, Li},
  title = {Characteristics of Gut Microbiota in Patients with Chronic Obstructive Pulmonary Disease Based on Metagenomics and Metabolomics},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  doi = {10.3390/ijms27104213}
}
Kostenlos starten →